• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种新颖的招募信息,旨在增加戒烟治疗计划的参与率:一项随机试验的初步结果。

A novel recruitment message to increase enrollment into a smoking cessation treatment program: preliminary results from a randomized trial.

机构信息

Department of Psychiatry, University of Pennsylvania, Philadelphia, 19104, USA.

出版信息

Health Commun. 2011 Dec;26(8):735-42. doi: 10.1080/10410236.2011.566829. Epub 2011 Jun 11.

DOI:10.1080/10410236.2011.566829
PMID:21667366
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4243839/
Abstract

Most smokers do not utilize approved interventions for nicotine dependence, reducing the probability of cessation. Smoking cessation programs typically use recruitment messages emphasizing the health threats of smoking. Augmenting this threat message by describing the genetic aspects of nicotine addiction may enhance enrollment into a cessation program. During telephone recruitment, 125 treatment-seeking smokers were randomized to receive by phone either a standard threat message or a threat plus genetic prime message and were offered open-label varenicline and counseling. There was a greater rate of enrollment into the cessation program for the threat plus genetic prime participants (51.7%) versus the threat-only participants (37.7%; p = .03). Smokers who self-identified from racial/ethnic minority groups were less likely to enroll in the cessation program (p = .01) versus smokers who self-identified as Caucasian. These preliminary data suggest that a simple, affordable, and transportable communication approach enhances enrollment of smokers into a smoking cessation program. A larger clinical trial to evaluate a genetic prime message for improving recruitment into smoking cessation programs is warranted.

摘要

大多数吸烟者不使用已批准的尼古丁依赖干预措施,从而降低了戒烟的可能性。戒烟计划通常使用招募信息来强调吸烟对健康的威胁。通过描述尼古丁成瘾的遗传方面来增强这种威胁信息,可能会增加戒烟计划的参与度。在电话招募期间,125 名寻求治疗的吸烟者被随机分为两组,一组通过电话接受标准的威胁信息,另一组接受威胁加遗传启动信息,并提供开放标签的伐伦克林和咨询。与仅接受威胁信息的参与者(37.7%)相比,接受威胁加遗传启动信息的参与者(51.7%)更有可能参加戒烟计划(p =.03)。与自认为是白种人的吸烟者相比,自认为来自少数族裔群体的吸烟者更不可能参加戒烟计划(p =.01)。这些初步数据表明,一种简单、经济实惠且可运输的沟通方法可以提高吸烟者参加戒烟计划的意愿。有必要进行更大规模的临床试验来评估遗传启动信息对提高戒烟计划招募效果的作用。

相似文献

1
A novel recruitment message to increase enrollment into a smoking cessation treatment program: preliminary results from a randomized trial.一种新颖的招募信息,旨在增加戒烟治疗计划的参与率:一项随机试验的初步结果。
Health Commun. 2011 Dec;26(8):735-42. doi: 10.1080/10410236.2011.566829. Epub 2011 Jun 11.
2
Nicotine receptor partial agonists for smoking cessation.用于戒烟的尼古丁受体部分激动剂。
Cochrane Database Syst Rev. 2012 Apr 18(4):CD006103. doi: 10.1002/14651858.CD006103.pub6.
3
Nicotine receptor partial agonists for smoking cessation.用于戒烟的尼古丁受体部分激动剂。
Cochrane Database Syst Rev. 2011 Feb 16(2):CD006103. doi: 10.1002/14651858.CD006103.pub5.
4
Nicotine receptor partial agonists for smoking cessation.用于戒烟的尼古丁受体部分激动剂。
Cochrane Database Syst Rev. 2010 Dec 8(12):CD006103. doi: 10.1002/14651858.CD006103.pub4.
5
Culturally-tailored smoking cessation for American Indians: study protocol for a randomized controlled trial.针对美洲印第安人的文化定制戒烟:一项随机对照试验的研究方案。
Trials. 2011 May 18;12:126. doi: 10.1186/1745-6215-12-126.
6
Behavioral counseling and varenicline treatment for smoking cessation.行为咨询和伐尼克兰治疗在戒烟中的应用。
Am J Prev Med. 2010 May;38(5):482-90. doi: 10.1016/j.amepre.2010.01.024.
7
Tobacco smoking cessation management: integrating varenicline in current practice.戒烟管理:将伐尼克兰纳入当前实践
Vasc Health Risk Manag. 2008;4(4):837-45. doi: 10.2147/vhrm.s3250.
8
Nicotine receptor partial agonists for smoking cessation.用于戒烟的尼古丁受体部分激动剂。
Cochrane Database Syst Rev. 2008 Jul 16(3):CD006103. doi: 10.1002/14651858.CD006103.pub3.
9
Efficacy of the nicotine vaccine 3'-AmNic-rEPA (NicVAX) co-administered with varenicline and counselling for smoking cessation: a randomized placebo-controlled trial.尼古丁疫苗 3'-AmNic-rEPA(NicVAX)联合伐尼克兰和咨询用于戒烟的疗效:一项随机安慰剂对照试验。
Addiction. 2014 Aug;109(8):1252-9. doi: 10.1111/add.12573. Epub 2014 Jun 3.
10
Combining Text Messaging and Telephone Counseling to Increase Varenicline Adherence and Smoking Abstinence Among Cigarette Smokers Living with HIV: A Randomized Controlled Study.结合短信与电话咨询以提高感染艾滋病毒的吸烟者对伐尼克兰的依从性及戒烟成功率:一项随机对照研究
AIDS Behav. 2017 Jul;21(7):1964-1974. doi: 10.1007/s10461-016-1538-z.

引用本文的文献

1
Nicotine receptor partial agonists for smoking cessation.尼古丁受体部分激动剂用于戒烟。
Cochrane Database Syst Rev. 2023 May 5;5(5):CD006103. doi: 10.1002/14651858.CD006103.pub8.
2
A Web-Based Intervention to Increase Smokers' Intentions to Participate in a Cessation Study Offered at the Point of Lung Screening: Factorial Randomized Trial.一项基于网络的干预措施,旨在提高吸烟者参与在肺部筛查点提供的戒烟研究的意愿:析因随机试验。
JMIR Form Res. 2021 Jun 30;5(6):e28952. doi: 10.2196/28952.
3
It's not just about recruitment: An exploratory look at tobacco education sessions to increase participation into smoking cessation programs among American Indians.这不仅仅关乎招募:对烟草教育课程的探索性研究,旨在提高美国印第安人参与戒烟项目的比例。
Health Educ Care. 2018 May 14;3(1):1-4. doi: 10.15761/hec.1000137.
4
Predictors of Enrollment of Older Smokers in Six Smoking Cessation Trials in the Lung Cancer Screening Setting: The Smoking Cessation at Lung Examination (SCALE) Collaboration.肺癌筛查环境下 6 项戒烟临床试验中招募老年吸烟者的预测因素:肺癌筛查中的戒烟合作研究(SCALE)。
Nicotine Tob Res. 2021 Nov 5;23(12):2037-2046. doi: 10.1093/ntr/ntab110.
5
Cessation classification likelihood increases with higher expired-air carbon monoxide cutoffs: a meta-analysis.停止分类可能性随着呼气一氧化碳截止值的升高而增加:一项荟萃分析。
Drug Alcohol Depend. 2021 Apr 1;221:108570. doi: 10.1016/j.drugalcdep.2021.108570. Epub 2021 Feb 3.
6
Nicotine receptor partial agonists for smoking cessation.用于戒烟的尼古丁受体部分激动剂。
Cochrane Database Syst Rev. 2016 May 9;2016(5):CD006103. doi: 10.1002/14651858.CD006103.pub7.
7
Sex Differences in Varenicline Efficacy for Smoking Cessation: A Meta-Analysis.伐尼克兰戒烟疗效的性别差异:一项荟萃分析。
Nicotine Tob Res. 2016 May;18(5):1002-11. doi: 10.1093/ntr/ntv207. Epub 2015 Oct 6.
8
Facebook Recruitment of Young Adult Smokers for a Cessation Trial: Methods, Metrics, and Lessons Learned.脸书招募年轻成年吸烟者参与戒烟试验:方法、指标及经验教训
Internet Interv. 2014 Apr;1(2):58-64. doi: 10.1016/j.invent.2014.05.001.
9
A double-blind placebo-controlled randomized trial of varenicline for smokeless tobacco dependence in India.一项在印度进行的关于伐伦克林治疗无烟烟草依赖的双盲安慰剂对照随机试验。
Nicotine Tob Res. 2014 Jan;16(1):50-7. doi: 10.1093/ntr/ntt115. Epub 2013 Aug 14.
10
Is a cancer diagnosis a teachable moment for the patient's relative who smokes?癌症诊断是否为患者的烟民亲属提供了一个可教育的时刻?
Cancer Causes Control. 2013 Jul;24(7):1339-46. doi: 10.1007/s10552-013-0212-2. Epub 2013 Apr 19.

本文引用的文献

1
Effectiveness of extended-duration transdermal nicotine therapy: a randomized trial.延长持续时间的透皮尼古丁疗法的疗效:一项随机试验。
Ann Intern Med. 2010 Feb 2;152(3):144-51. doi: 10.7326/0003-4819-152-3-201002020-00005.
2
Cigarette smoking among adults and trends in smoking cessation - United States, 2008.2008年美国成年人吸烟情况及戒烟趋势
MMWR Morb Mortal Wkly Rep. 2009 Nov 13;58(44):1227-32.
3
Predictors of enrollment in a smoking cessation clinical trial after eligibility screening.资格筛查后戒烟临床试验入组的预测因素。
J Natl Med Assoc. 2009 May;101(5):450-5. doi: 10.1016/s0027-9684(15)30931-7.
4
Racial/Ethnic disparities in the use of nicotine replacement therapy and quit ratios in lifetime smokers ages 25 to 44 years.25至44岁成年吸烟者在使用尼古丁替代疗法及戒烟率方面的种族/民族差异。
Cancer Epidemiol Biomarkers Prev. 2008 Jul;17(7):1640-7. doi: 10.1158/1055-9965.EPI-07-2726. Epub 2008 Jun 26.
5
Nicotine replacement therapy: perceptions of African-American smokers seeking to quit.尼古丁替代疗法:对寻求戒烟的非裔美国吸烟者的认知
J Natl Med Assoc. 2008 Feb;100(2):230-6. doi: 10.1016/s0027-9684(15)31211-6.
6
Varenicline versus transdermal nicotine patch for smoking cessation: results from a randomised open-label trial.伐尼克兰与经皮尼古丁贴片用于戒烟:一项随机开放标签试验的结果
Thorax. 2008 Aug;63(8):717-24. doi: 10.1136/thx.2007.090647. Epub 2008 Feb 8.
7
Treating tobacco dependence in women.治疗女性烟草依赖。
J Womens Health (Larchmt). 2007 Oct;16(8):1211-8. doi: 10.1089/jwh.2006.0281.
8
Why do those who request smoking treatment fail to attend the first appointment?为什么那些寻求戒烟治疗的人未能参加首次预约?
J Subst Abuse Treat. 2008 Jul;35(1):62-7. doi: 10.1016/j.jsat.2007.08.009. Epub 2007 Oct 10.
9
Current and emerging pharmacotherapies for treating tobacco dependence.治疗烟草依赖的现有及新兴药物疗法。
Expert Opin Emerg Drugs. 2006 Sep;11(3):429-44. doi: 10.1517/14728214.11.3.429.
10
Efficacy of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: a randomized controlled trial.伐尼克兰(一种α4β2烟碱型乙酰胆碱受体部分激动剂)与安慰剂或缓释安非他酮用于戒烟的疗效:一项随机对照试验。
JAMA. 2006 Jul 5;296(1):56-63. doi: 10.1001/jama.296.1.56.